Skip to main content

Month: April 2020

F-Secure Oyj – Johdon liiketoimet – Eriikka Söderström

F-Secure Oyj, Pörssitiedote, 7.4.2020 klo 16:00F-Secure Oyj – Johdon liiketoimet – Eriikka SöderströmF-Secure Oyj – Johdon liiketoimet____________________________________________IlmoitusvelvollinenNimi: Söderström, EriikkaAsema: TalousjohtajaLiikkeeseenlaskija: F-Secure OyjLEI: 743700ATXLT0MFCHXT16Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 743700ATXLT0MFCHXT16_20200407120831_3____________________________________________Liiketoimen päivämäärä: 2020-04-06Kauppapaikka ei sovelluInstrumenttityyppi: OSAKEISIN: FI0009801310Liiketoimen luonne: OSAKEPALKKION VASTAANOTTAMINENLiiketoimien yksityiskohtaiset tiedot(1): Volyymi: 660 Yksikköhinta: EURLiiketoimien yhdistetyt tiedot(1): Volyymi: 660 Keskihinta: EUR Lisätietoja:Henri Kiili,  Johtaja – Sijoittajasuhteet ja Treasury, F-Secure Oyj +358 40 840 5450investor-relat...

Continue reading

Lexia PowerUp Literacy Named a Finalist in 2020 SIIA CODiE Awards

BOSTON, April 07, 2020 (GLOBE NEWSWIRE) — Lexia Learning, a Rosetta Stone company (NYSE: RST), today announced that its personalized literacy program Lexia® PowerUp Literacy® was chosen as a 2020 SIIA CODiE Award finalist in the Best Reading/Writing/Literature Instructional Solution for Grades 9-12 and Higher Education category.Developed to address the decades-long gap in reading proficiency across the nation, PowerUp is designed to enhance core English language arts instruction for struggling readers in grades 6–12. Research has shown that PowerUp is up to five times as effective as the average middle school reading intervention. By blending online student-driven instruction with offline teacher-delivered lessons and activities, the program accelerates the development of both fundamental literacy skills and higher-order thinking...

Continue reading

BBS-Bioactive Bone Substitutes Oyj: ARTEBONE®-tuotteelle on myönnetty patentti USA:ssa

Yhtiömme BBS-Bioactive Bone Substitutes Oyj:n patenttihakemuksen ”A METHOD FOR PREPARING A BONE PROTEIN PREPARATION AND A BONE PROTEIN PREPARATION” tuotevaatimukset on hyväksytty USA:ssa. Nyt yhtiön ARTEBONE®-tuotteelle on myönnetty patentti kaikissa maissa, joissa sitä on haettu. USA:n osalta on vielä menossa tuotteen valmistusta koskeva patenttihakemus. Lisätietoja:Ilkka Kangasniemi, toimitusjohtaja, puh. +35840 7080 307, s-posti: ilkka.kangasniemi@bbs-artebone.fiHyväksytty neuvonantaja: Stockholm Certified Advisers AB, puh. +46 70 5516 729, info@certifiedadviser.seJAKELU:Nasdaq Helsinki OyNasdaq Stockholm ABKeskeiset tiedotusvälineetwww.bbs-artebone.fiTämä on tieto, jonka BBS-Bioactive Bone Substitutes Oyj on velvollinen julkistamaan EU:n markkinoiden väärinkäytön asetuksen mukaisesti. Tiedot on toimitettu julkaisemista varten edellä...

Continue reading

AS Tallinna Sadam 2020 Q1 passenger and cargo flows

In 2020 Q1, 4.8 million tonnes of cargo and 1.6 million passengers passed through the harbours of Tallinna Sadam. Compared to the same period of previous year, the cargo volume increased 2.0%. The number of passengers in Q1 decreased by 13.3%. The number of ship calls declined by 2.9% to 1585 calls.In terms of passenger numbers, the results of Q1 were mostly affected by the COVID-19 pandemic that broke out in March and the related special measures established in Estonia and neighboring countries, as well as restrictions on passenger transport. The Tallinn-Stockholm route was temporarily closed as of 15 March, and passenger traffic on the Tallinn-Helsinki route decreased significantly in the second half of March due to the closure of the Estonian and Finnish borders for passengers. Operators have also reduced the number of ships sailing...

Continue reading

F-Secure Corporation – Managers’ Transactions – Jari Still

F-Secure Corporation, Stock Exchange Release, 7 April 2020, at 16.00 EESTF-Secure Corporation – Managers’ Transactions – Jari StillF-Secure Oyj – Managers’ Transactions____________________________________________Person subject to the notification requirementName: Still, JariPosition: Other senior managerIssuer: F-Secure OyjLEI: 743700ATXLT0MFCHXT16Notification type: INITIAL NOTIFICATIONReference number: 743700ATXLT0MFCHXT16_20200407120702_3____________________________________________Transaction date: 2020-04-06Venue not applicableInstrument type: SHAREISIN: FI0009801310Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATIONTransaction details(1): Volume: 660 Unit price: EURAggregated transactions(1): Volume: 660 Volume weighted average price: EUR Contact information:Henri Kiili,  Investor Relations...

Continue reading

F-Secure Oyj – Johdon liiketoimet – Jari Still

F-Secure Oyj, Pörssitiedote, 7.4.2020 klo 16:00F-Secure Oyj – Johdon liiketoimet – Jari StillF-Secure Oyj – Johdon liiketoimet____________________________________________IlmoitusvelvollinenNimi: Still, JariAsema: Muu ylin johtoLiikkeeseenlaskija: F-Secure OyjLEI: 743700ATXLT0MFCHXT16Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 743700ATXLT0MFCHXT16_20200407120702_3____________________________________________Liiketoimen päivämäärä: 2020-04-06Kauppapaikka ei sovelluInstrumenttityyppi: OSAKEISIN: FI0009801310Liiketoimen luonne: OSAKEPALKKION VASTAANOTTAMINENLiiketoimien yksityiskohtaiset tiedot(1): Volyymi: 660 Yksikköhinta: EURLiiketoimien yhdistetyt tiedot(1): Volyymi: 660 Keskihinta: EURLisätietoja:Henri Kiili,  Johtaja – Sijoittajasuhteet ja Treasury, F-Secure Oyj +358 40 840 5450investor-relations@f-secure.com

Continue reading

REPEAT – QuestCap Announces Profit Sharing on Exclusive Distribution Contract

TORONTO, April 07, 2020 (GLOBE NEWSWIRE) — QuestCap Inc. (“QuestCap” or the “Company”) (CSE: QSC; FRA: 34C1) announced today that it has entered into a profit sharing agreement with More Than Just Rice, Inc. (“MTJR”), subject to the satisfaction of conditions with a Korean diagnostic testing company, for MTJR to exclusively distribute, market and sell COVID19 Antibody Tests in North and South America.  The test will be marketed/distributed in the United States pursuant to the U.S. Food and Drug Administration (FDA)’s policy on COVID-19 serological tests during the public health emergency period.COVID-19 Antibody Test Disclaimers:This test has not been reviewed by the FDA.Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic...

Continue reading

Monatliche Information zur Gesamtzahl der Stimmrechte und Anteile, aus denen sich das Aktienkapital zusammensetzt – Dienstag, 31. März 2020

Lyon, Frankreich, April 07, 2020 (GLOBE NEWSWIRE) — Artikel 223-16 der allgemeinen Verordnung der französischen Autorité des Marchés FinanciersLyon – FrankreichBörsennotierung:Euronext Paris von Euronext (Marktsegment C – ISIN-Code: FR0011471135 – Symbol: ERYP) &Nasdaq Global Select Market in den USA (Symbol: ERYP)Website: www.erytech.com        1Die Anzahl der Bruttostimmrechte (bzw. „theoretischen“ Stimmrechte) dient als Grundlage für die Berechnung des Schwellenwerts. Gemäß Artikel 223-11 der allgemeinen Verordnung der Autorité des Marchés Financiers wird diese Zahl auf Basis aller Anteile berechnet, die einfache und doppelte Stimmrechte umfassen, einschließlich Aktien ohne Stimmrechte.2Ohne eigene Aktien.

Continue reading

Informazioni mensili relative al numero totale dei diritti di voto e delle azioni che compongono il capitale sociale – martedì 31 marzo 2020

Lione, Francia, April 07, 2020 (GLOBE NEWSWIRE) —Articolo 223-16 del regolamento generale dell’Autorité des Marchés Financiers franceseLione – FranciaMercati di quotazione:Euronext Paris di Euronext (segmento di mercato C –  codice ISIN: FR0011471135 – simbolo: ERYP) eNasdaq Global Select Market negli Stati Uniti (Simbolo: ERYP)Sito web: www.erytech.com        (1)   Il numero dei diritti di voto lordi (o diritti di voto “teorici”) è utilizzato come base per il calcolo del superamento della soglia. Ai sensi dell’articolo 223-11 del regolamento generale dell’Autorité des Marchés Financiers, questo numero è calcolato sulla base di tutte le azioni con diritto di voto unico e doppio, ivi comprese le azioni senza diritto di voto.(2)   Escluse le azioni proprie.

Continue reading

FEMA’s ‘Project Airbridge’ Takes Flight With 25 UPS Charter Flights, Dedicated FEMA Distribution Center

ATLANTA, April 07, 2020 (GLOBE NEWSWIRE) —UPS managing and brokering 25 flights over the next two weeksUPS-managed Project Airbridge flights delivering more than three million pounds of materials including masks, surgical gowns, gloves, medical swabs and thermometers in high-demand within the U.S. healthcare systemShipments originating from China, Malaysia, Honduras, among other countriesUPS opening new 450,000 square-foot UPS Healthcare facility in Louisville with dedicated space for FEMA UPS managing 24/7 operation of receipt and distribution of PPE, at FEMA’s directionUPS (NYSE:UPS) today announced the company is managing and brokering 25 charter flights in support of Project Airbridge, a coordinated effort between the Federal Emergency Management Agency (FEMA), numerous countries and the private sector designed to expedite the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.